Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications.
Ryosuke Shirasaki,Ricardo de Matos Simoes,Sara Gandolfi,Geoffrey Matthews,Dennis Buckley,Joseline Raja,Quinlan Sievers,Johanna Bruggenthies,Olga Dashevsky,Haley Poarch,Huihui Tang,Megan Bariteau,Michal Sheffer,Yiguo Hu,Sondra Downey-Kopyscinski,Paul Hengeveld,Brian J. Glassner,Eugen Dhimolea,Christopher Ott,Tinghu Zhang,Nicholas Kwiatkowski,Jacob Laubach,Robert Schlossman,Aedin Culhane,Paul G. Richardson,Richard Groen,Eric Fischer,Francisca Vazquez,Aviad Tsherniak,William Hahn,Joan Levy,Daniel Auclair,Jonathan Licht,Jonathan Keats,Lawrence Boise,Benjamin Ebert, James Bradner,Nathanael Gray,Constantine Mitsiades CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)
关键词
E3 ligase,High-risk cytogenetics,PROTACs
AI 理解论文
溯源树
样例